Table 3.

Common treatment‐related adverse events (AEs)

	Grade 1	Grade 2	Grade 3	All grade
	n (%)	n (%)	n (%)	n (%)
Neutropenia	2 (9.5)	4 (19.0)	0	6 (28.6)
Anemia	15 (71.4)	0	0	15 (71.4)
Thrombocytopenia	3 (14.3)	0	0	3 (14.3)
Febrile neutropenia	—	—	0	0
Increased AST	2 (9.5)	0	0	2 (9.5)
Increased ALT	4 (19.0)	0	0	4 (19.0)
Increased creatinine	1 (4.8)	0	0	1 (4.8)
Anorexia	9 (42.9)	4 (19.0)	2 (9.5)	15 (71.4)
Vomiting	5 (23.8)	0	0	5 (23.8)
Diarrhea	1(4.8)	0	0	1 (4.8)
Pneumonitis	1(4.8)	0	0	1 (4.8)
Gingival pain	2 (9.5)	0	0	2 (9.5)
Rash	1 (4.8)	0	0	1 (4.8)
Thromboembolism	0	0	1 (4.8)	1 (4.8)
Infection without neutropenia	0	1 (4.8)	0	1 (4.8)